Mimedx Group SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 28, 2026, 4:03 p.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedMiMedx Q3 2026 net sales fall 45% to $62.3 million, missing $68.7 million consensus; FY2026 sales guidance of $250-260 million sits below $267 million consensus
10-QOct. 28, 2026, 4:03 p.m. ETView on SEC.gov
8-KOct. 16, 2026, 9:01 a.m. ETView on SEC.gov
Other events
8-K/AAug. 11, 2026, 4:44 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits
8-KJuly 29, 2026, 4:08 p.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
10-QJuly 29, 2026, 4:06 p.m. ETView on SEC.gov
8-KJuly 29, 2026, 4:03 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits